Chinese Bt rice may not go commercial due to ‘societal pressures,’ not safety concerns

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Multiple lines of transgenic rice expressing insecticidal genes from the bacteriumย Bacillus thuringiensisย (Bt) have been developed in China, posing the prospect of increases in production with decreased application of pesticides. A body of safety assessment work onย Btย rice has shown thatย Btย rice poses a negligible risk to the environment and thatย Btย rice products are as safe as non-Btย control rice products as food.

China has a relatively well-developed regulatory system for risk assessment and management of genetically modified (GM) plants; however, decision-making regarding approval of commercial production has become politicized, and twoย Btย rice lines that otherwise were ready have not been allowed to enter the Chinese agricultural system.

We predict that Chinese farmers would value the prospect of increased yield with decreased use of pesticide and would readily adopt production ofย Btย rice. Thatย Btย rice lines may not be commercialized in the near future we attribute to social pressures, largely due to the low level of understanding and acceptance of GM crops by Chinese consumers.

Hence, enhancing communication of GM crop science-related issues to the public is an important, unmet need.

Read full, original post:ย The development and status of Bt rice in China

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesnโ€™t change the scienceโ€”the worldโ€™s most popular herbicide is safeย 
Picture1
The FDA couldnโ€™t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
global warming
โ€˜Implausibleโ€™: Top climate scientists reject worst-case scenarioโ€”soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limitedโ€“at best
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research showsโ€”but not for blacks and ethnic minorities
Screenshot-2026-05-20-at-5.11.17-PM
Viewpoint: No, sugar doesnโ€™t โ€˜feedโ€™ cancer โ€” common cancer myths, debunked

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.